首页> 美国卫生研究院文献>Health and Quality of Life Outcomes >The impact of patient-reported outcome (PRO) data from clinical trials: a systematic review and critical analysis
【2h】

The impact of patient-reported outcome (PRO) data from clinical trials: a systematic review and critical analysis

机译:来自临床试验的患者报告结果(PRO)数据的影响:系统评价和关键分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundPatient-reported outcomes (PROs) are commonly collected in clinical trials and should provide impactful evidence on the effect of interventions on patient symptoms and quality of life. However, it is unclear how PRO impact is currently realised in practice. In addition, the different types of impact associated with PRO trial results, their barriers and facilitators, and appropriate impact metrics are not well defined. Therefore, our objectives were: i) to determine the range of potential impacts from PRO clinical trial data, ii) identify potential PRO impact metrics and iii) identify barriers/facilitators to maximising PRO impact; and iv) to examine real-world evidence of PRO trial data impact based on Research Excellence Framework (REF) impact case studies.
机译:背景患者报告的结局(PRO)通常在临床试验中收集,并应提供干预措施对患者症状和生活质量的影响的有力证据。然而,目前尚不清楚在实践中如何实现PRO的影响。此外,与PRO试验结果相关的不同类型的影响,其障碍和促进因素以及适当的影响指标还没有很好地定义。因此,我们的目标是:i)从PRO临床试验数据中确定潜在影响的范围,ii)确定潜在PRO影响指标,iii)确定最大程度地发挥PRO影响的障碍/促进因素; iv)根据研究卓越框架(REF)影响案例研究,检查PRO试验数据影响的现实证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号